KKR & Co. Inc. (NYSE:KKR) Price Target Raised to $150.00

KKR & Co. Inc. (NYSE:KKR) had its price objective upped by stock analysts at JMP Securities from $135.00 to $150.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has a “market outperform” rating on the asset manager’s stock. JMP Securities’ price target would suggest a potential upside of 12.66% from the company’s previous close.

A number of other research firms also recently weighed in on KKR. Citigroup raised their price target on KKR & Co. Inc. from $130.00 to $150.00 and gave the stock a “buy” rating in a research note on Friday, August 2nd. Keefe, Bruyette & Woods reaffirmed an “outperform” rating and set a $144.00 price target (up from $125.00) on shares of KKR & Co. Inc. in a research note on Thursday, August 1st. Evercore ISI raised their price target on KKR & Co. Inc. from $112.00 to $117.00 and gave the stock an “outperform” rating in a research note on Monday, July 15th. Wells Fargo & Company initiated coverage on KKR & Co. Inc. in a research note on Thursday, September 12th. They set an “equal weight” rating and a $130.00 price target for the company. Finally, Hsbc Global Res raised KKR & Co. Inc. to a “strong-buy” rating in a research note on Wednesday, September 18th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, KKR & Co. Inc. has an average rating of “Moderate Buy” and an average target price of $141.00.

KKR & Co. Inc. Stock Down 1.3 %

Shares of KKR & Co. Inc. stock opened at $133.14 on Wednesday. The stock has a 50-day moving average price of $122.66 and a 200 day moving average price of $110.91. The company has a market cap of $118.15 billion, a P/E ratio of 31.40, a P/E/G ratio of 1.14 and a beta of 1.62. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.86. KKR & Co. Inc. has a 1 year low of $53.72 and a 1 year high of $135.25.

KKR & Co. Inc. (NYSE:KKR) last announced its quarterly earnings data on Wednesday, July 31st. The asset manager reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.20. KKR & Co. Inc. had a return on equity of 5.05% and a net margin of 17.99%. The firm had revenue of $4.17 billion during the quarter, compared to the consensus estimate of $1.07 billion. During the same period in the prior year, the business earned $0.58 EPS. As a group, analysts expect that KKR & Co. Inc. will post 3.97 EPS for the current fiscal year.

Insider Buying and Selling at KKR & Co. Inc.

In other KKR & Co. Inc. news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the firm’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $25.75, for a total value of $149,350,000.00. Following the sale, the insider now owns 25,260,971 shares of the company’s stock, valued at $650,470,003.25. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, major shareholder Kkr Group Partnership L.P. acquired 11,619,998 shares of the firm’s stock in a transaction dated Wednesday, September 11th. The shares were bought at an average price of $11.13 per share, with a total value of $129,330,577.74. Following the acquisition, the insider now owns 92,959,984 shares of the company’s stock, valued at $1,034,644,621.92. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of KKR & Co. Inc. stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $25.75, for a total value of $149,350,000.00. Following the sale, the insider now directly owns 25,260,971 shares in the company, valued at $650,470,003.25. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 39.34% of the company’s stock.

Institutional Trading of KKR & Co. Inc.

Several institutional investors have recently modified their holdings of KKR. Washington Trust Bank acquired a new stake in shares of KKR & Co. Inc. during the 4th quarter worth approximately $219,000. Cobalt Capital Management Inc. grew its holdings in shares of KKR & Co. Inc. by 275.0% during the 4th quarter. Cobalt Capital Management Inc. now owns 150,000 shares of the asset manager’s stock worth $12,428,000 after purchasing an additional 110,000 shares in the last quarter. Bridgefront Capital LLC acquired a new stake in shares of KKR & Co. Inc. during the 4th quarter worth approximately $571,000. BlueCrest Capital Management Ltd bought a new position in shares of KKR & Co. Inc. during the 4th quarter worth approximately $356,000. Finally, Bain Capital Public Equity LP bought a new position in shares of KKR & Co. Inc. during the 4th quarter worth approximately $4,407,000. Institutional investors and hedge funds own 76.26% of the company’s stock.

About KKR & Co. Inc.

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.